Tandem Diabetes Care reports its operating margin is negative at -4.4%, its EBITDA margin is negative at -3.3%, and its net margin is negative at -6.1%, alongside a gross margin of 56%, an operating margin of -4.4%, an EBITDA margin of -3.3%, and a net margin of -6.1%. Operating margin had the largest improvement, increasing by 15.5 percentage points, while the other available margins also improved.
Looking back over the last 3 years, Tandem Diabetes Care recorded average margins of 52.01% gross, -16.59% operating, -13.69% EBITDA, and -16.84% net. Compared with their three-year averages, all four current margins are higher.
Year over year, gross, operating, EBITDA, and net margins all increased, with operating margin showing the largest gain at 15.5 percentage points.
The average gross margin for Tandem Diabetes Care was 52.01% during the last 3 years. At present, the current gross margin for Tandem Diabetes Care is 56%, 4 percentage points above its three-year average. The gross margin for Tandem Diabetes Care moved between 49.1% in Jun 2024 and 56% in Jun 2026.
Across the last 3 years, Tandem Diabetes Care's operating margin stood at -16.59%. Against its three-year average, Tandem Diabetes Care's operating margin is currently -4.4%, 12.2 percentage points above its three-year average. Operating margin was highest at -4.4% in Jun 2026 and lowest at -31.2% in Dec 2023.
Tandem Diabetes Care's EBITDA margin averaged -13.69% across the past 3 years. Compared with its three-year average, Tandem Diabetes Care's current EBITDA margin is -3.3% and is 10.4 percentage points above its three-year average. Over the last 3 years, Tandem Diabetes Care's EBITDA margin peaked at -3.3% in Jun 2026 and reached a low of -26% in Dec 2023.
Tandem Diabetes Care recorded an average net margin of -16.84% across the last 3 years. Tandem Diabetes Care currently reports a net margin of -6.1%, 10.7 percentage points above its three-year average. Over the last 3 years, Tandem Diabetes Care's net margin peaked at -6.1% in Jun 2026 and reached a low of -29.8% in Dec 2023.
Tandem Diabetes Care's gross margin of 56% is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 68.4%, Tandem Diabetes Care's gross margin is 18% lower.
As of Jun 30, 2026, TNDM has a gross margin of 56%.
The current operating margin for TNDM is -4.4% as of Jun 30, 2026.
For the period ending Jun 30, 2026, TNDM recorded an EBITDA margin of -3.3%.
As of Jun 30, 2026, TNDM has a net margin of -6.1%.
Over the last 3 years, Tandem Diabetes Care's margins averaged 52.0% gross, -16.6% operating, -13.7% EBITDA, and -16.8% net.
Tandem Diabetes Care's highest recorded margins during the past 5 years were 56% gross in Jun 2026, 3.2% operating in Dec 2021, 5.1% EBITDA in Dec 2021, and 2.2% net in Dec 2021.
Tandem Diabetes Care's lowest recorded margins during the past 5 years were 49.1% gross in Jun 2024, -31.2% operating in Dec 2023, -26% EBITDA in Dec 2023, and -29.8% net in Dec 2023.